2.4000
+0.3300
+(15.94%)
At close: April 11 at 4:00:02 PM EDT
2.3500
-0.05
(-2.08%)
After hours: April 11 at 7:26:33 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 6 | 5 |
| Avg. Estimate | -0.14 | -0.14 | -0.66 | -0.59 |
| Low Estimate | -0.19 | -0.18 | -0.8 | -0.76 |
| High Estimate | -0.11 | -0.12 | -0.46 | -0.39 |
| Year Ago EPS | -0.14 | -0.13 | -0.55 | -0.66 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 9 | 7 |
| Avg. Estimate | 7.12M | 6.71M | 26.29M | 34.76M |
| Low Estimate | 4.6M | 4.67M | 17.8M | 14.8M |
| High Estimate | 17M | 12M | 50M | 60M |
| Year Ago Sales | 9.95M | 7.32M | 28.83M | 26.29M |
| Sales Growth (year/est) | -28.43% | -8.32% | -8.82% | 32.21% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.16 | -0.14 | -0.13 | -0.15 |
| EPS Actual | -0.14 | -0.13 | -0.17 | -0.12 |
| Difference | 0.02 | 0.01 | -0.04 | 0.03 |
| Surprise % | 13.28% | 9.30% | -30.77% | 20.76% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.14 | -0.14 | -0.66 | -0.59 |
| 7 Days Ago | -0.17 | -0.19 | -0.68 | -0.56 |
| 30 Days Ago | -0.17 | -0.19 | -0.68 | -0.56 |
| 60 Days Ago | -0.17 | -0.19 | -0.68 | -0.56 |
| 90 Days Ago | -0.17 | -0.19 | -0.68 | -0.56 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 1 | 1 |
| Up Last 30 Days | 1 | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | 2 | 2 |
| Down Last 30 Days | -- | -- | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ABCL | -1.79% | -11.54% | -20.61% | 10.75% |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Reiterates | Benchmark: Hold to Hold | 3/3/2025 |
| Maintains | Stifel: Buy to Buy | 2/28/2025 |
| Maintains | Keybanc: Overweight to Overweight | 1/8/2025 |
| Reiterates | Benchmark: Hold | 11/5/2024 |
| Reiterates | Stifel: Buy to Buy | 11/5/2024 |
| Downgrade | Benchmark: Buy to Hold | 8/20/2024 |
Related Tickers
ABSI Absci Corporation
3.0200
+23.01%
NTLA Intellia Therapeutics, Inc.
7.41
+9.45%
BEAM Beam Therapeutics Inc.
15.47
+5.74%
DNA Ginkgo Bioworks Holdings, Inc.
8.12
+11.23%
RXRX Recursion Pharmaceuticals, Inc.
5.76
+27.72%
PRME Prime Medicine, Inc.
1.3300
+13.68%
VERV Verve Therapeutics, Inc.
3.2600
+6.89%
EDIT Editas Medicine, Inc.
1.3000
+17.12%
CRBU Caribou Biosciences, Inc.
0.8743
+1.72%
VIR Vir Biotechnology, Inc.
5.53
+4.73%